In humans, de novo mutations in CaMKII have been identified and reported majorly in cases of neurodevelopmental disorders (NDDs) (Study, 2017; Akita et al., 2018) and intellectual disability (ID) (Küry et al., 2017). Here, CAMK2G is linked to neurodevelopmental disorder.